Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review
Crosses the blood brain barrier
Whether such a low dose provides meaningful metabolic benefit is questionable
Nebulzation takes 10-15 minutes and may be repeated every hour or so
AOD-9604, sometimes called the fat-burning peptide, showed limited promise in animal studies but has failed to demonstrate consistent results in people, leading the FDA to explicitly state it is not an approved treatment (FDA on unapproved drugs)
It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such